Published in Proc Natl Acad Sci U S A on August 12, 2002
Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) (2010) 2.48
Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol (2010) 1.91
RNAPol-ChIP: a novel application of chromatin immunoprecipitation to the analysis of real-time gene transcription. Nucleic Acids Res (2004) 1.86
MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology (2010) 1.64
A molecular wound response program associated with regeneration initiation in planarians. Genes Dev (2012) 1.41
Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid. Am J Physiol Gastrointest Liver Physiol (2010) 1.38
Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection. Mol Cell Biol (2006) 1.36
Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling. J Clin Invest (2008) 1.23
Proteomic analysis of blastema formation in regenerating axolotl limbs. BMC Biol (2009) 1.16
Temporal and functional profile of the transcriptional regulatory network in the early regenerative response to partial hepatectomy in the rat. BMC Genomics (2008) 1.07
p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology (2009) 0.99
A model of liver regeneration. Biophys J (2009) 0.95
Carbon monoxide enhances early liver regeneration in mice after hepatectomy. Hepatology (2011) 0.94
Down-regulation of MiR-127 facilitates hepatocyte proliferation during rat liver regeneration. PLoS One (2012) 0.94
Relationships between deficits in tissue mass and transcriptional programs after partial hepatectomy in mice. Am J Pathol (2009) 0.93
The genetic regulation of the terminating phase of liver regeneration. Comp Hepatol (2012) 0.91
To divide or not to divide: revisiting liver regeneration. Cell Div (2013) 0.91
Expressed genes in regenerating rat liver after partial hepatectomy. World J Gastroenterol (2005) 0.90
Cascades of transcription regulation during liver regeneration. Int J Biochem Cell Biol (2010) 0.89
TLRs, NF-κB, JNK, and Liver Regeneration. Gastroenterol Res Pract (2010) 0.86
Monocyte-endothelial cell interactions in the regulation of vascular sprouting and liver regeneration in mouse. J Hepatol (2015) 0.84
Accelerated partial hepatectomy-induced liver cell proliferation is associated with liver injury in Nur77 knockout mice. Am J Pathol (2014) 0.84
Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice. Hepatology (2010) 0.83
Identification and characterization of 177 unreported genes associated with liver regeneration. Genomics Proteomics Bioinformatics (2004) 0.81
Gene positional changes relative to the nuclear substructure correlate with the proliferating status of hepatocytes during liver regeneration. Nucleic Acids Res (2003) 0.81
liver-enriched gene 1a and 1b encode novel secretory proteins essential for normal liver development in zebrafish. PLoS One (2011) 0.80
Enucleation-induced rat adrenal gland regeneration: expression profile of selected genes involved in control of adrenocortical cell proliferation. Int J Endocrinol (2014) 0.79
Hepatic retinoid stores are required for normal liver regeneration. J Lipid Res (2013) 0.79
P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy. Am J Physiol Gastrointest Liver Physiol (2014) 0.78
Increased sinusoidal flow is not the primary stimulus to liver regeneration. Comp Hepatol (2010) 0.78
Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma. Oncotarget (2015) 0.78
A novel comparative pattern analysis approach identifies chronic alcohol mediated dysregulation of transcriptomic dynamics during liver regeneration. BMC Genomics (2016) 0.77
Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. World J Gastroenterol (2008) 0.77
Integrative genomics: liver regeneration and hepatocellular carcinoma. J Cell Biochem (2012) 0.77
A novel comparative pattern count analysis reveals a chronic ethanol-induced dynamic shift in immediate early NF-κB genome-wide promoter binding during liver regeneration. Mol Biosyst (2016) 0.76
Heterogeneity of transcription factor binding specificity models within and across cell lines. Genome Res (2016) 0.76
Systems Analysis of the Complement-Induced Priming Phase of Liver Regeneration. J Immunol (2016) 0.75
Monocyte chemoattractant protein-1 is not required for liver regeneration after partial hepatectomy. J Inflamm (Lond) (2016) 0.75
A genetic screen reveals Foxa3 and TNFR1 as key regulators of liver repopulation. Genes Dev (2015) 0.75
Characteristics of intracellular Ca(2+) signals consisting of two successive peaks in hepatocytes during liver regeneration after 70% partial hepatectomy in rats. J Exp Pharmacol (2016) 0.75
Preexposure to Olive Oil Polyphenols Extract Increases Oxidative Load and Improves Liver Mass Restoration after Hepatectomy in Mice via Stress-Sensitive Genes. Oxid Med Cell Longev (2016) 0.75
BubR1 Insufficiency Impairs Liver Regeneration in Aged Mice after Hepatectomy through Intercalated Disc Abnormality. Sci Rep (2016) 0.75
How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol (2001) 14.05
Liver regeneration. Science (1997) 12.80
The biology of chemokines and their receptors. Annu Rev Immunol (2000) 9.81
Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (1996) 6.70
Roles of PPARs in health and disease. Nature (2000) 5.87
High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81
Liver regeneration. J Hepatol (2000) 5.22
CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A (1998) 3.18
Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol (1997) 3.15
Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol (1999) 2.67
Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J (1995) 2.64
Liver regeneration 4: transcriptional control of liver regeneration. FASEB J (1996) 2.31
Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology (2000) 2.24
Amphibian limb regeneration: rebuilding a complex structure. Science (1997) 2.19
Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology (1995) 2.17
The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem (2001) 2.13
Hepatic stem cells in liver regeneration. FASEB J (1996) 2.07
Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat Genet (1996) 1.88
Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol (2000) 1.71
Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol (1992) 1.64
Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology (1998) 1.60
Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem (2001) 1.52
The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol Metab (2000) 1.44
CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain. J Biol Chem (2001) 1.43
Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis (1999) 1.41
The role of interferon regulatory factors in the interferon system and cell growth control. Biochimie (1999) 1.40
In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology (1994) 1.38
Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol Cell Biol (2001) 1.37
IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res (2002) 1.36
High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest (1995) 1.33
The roles of ATF3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas. J Biol Chem (2001) 1.31
Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol (2000) 1.29
Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology (2001) 1.29
Signal transduction. How do cells sense oxygen? Science (2001) 1.27
Liver stem cells. Mod Pathol (1994) 1.25
Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci U S A (2000) 1.22
A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell (2000) 1.16
Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology (2001) 1.14
Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism. Bone (2001) 1.14
Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. Gene Expr (1999) 1.11
The interferon regulatory factors and oncogenesis. Semin Cancer Biol (2000) 1.03
Expression of CLCN voltage-gated chloride channel genes in human blood vessels. J Mol Cell Cardiol (1999) 1.02
Timing of hepatocyte entry into DNA synthesis after partial hepatectomy is cell autonomous. Proc Natl Acad Sci U S A (2000) 1.01
The role of Kupffer cells in liver regeneration. Arch Histol Cytol (1999) 0.99
Isolation and characterization of gap junctions from tissue culture cells. J Mol Biol (2002) 0.99
Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity. Proc Natl Acad Sci U S A (2001) 0.98
Raf and fibroblast growth factor phosphorylate Elk1 and activate the serum response element of the immediate early gene pip92 by mitogen-activated protein kinase-independent as well as -dependent signaling pathways. Mol Cell Biol (1998) 0.95
Structure and localization of the IGFBP-1 gene and its expression during liver regeneration. Hepatology (1994) 0.94
Differential regulation of immediate early gene expression in preadipocyte cells through multiple signaling pathways. Biochem Biophys Res Commun (1999) 0.92
Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells. J Hepatol (1999) 0.92
Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2. Mol Cell Endocrinol (1999) 0.92
Importance of local proliferation in the expanding Kupffer cell population of rat liver after zymosan stimulation and partial hepatectomy. Hepatology (1984) 0.89
Neuroinflammation in the rat--CNS cells and their role in the regulation of immune reactions. Immunol Rev (2001) 0.86
Stimulation of regeneration in mammals: pipe dream or realistic goal? Wound Repair Regen (1999) 0.85
Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors. J Neuropathol Exp Neurol (2001) 0.83
The role of the activin-follistatin system in the developmental and regeneration processes of the kidney. Cytokine Growth Factor Rev (2001) 0.83
Cell and tissue-type specific expression of Ras-related GTPase RhoB. Anticancer Res (1999) 0.82
Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells. Carcinogenesis (2002) 0.80
Hepatoprotective action of adenovirus-transferred HNF-3gamma gene in acute liver injury caused by CCl(4). FEBS Lett (1999) 0.77
Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A (2002) 25.47
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A (2005) 14.78
Coordinated transcription of key pathways in the mouse by the circadian clock. Cell (2002) 14.07
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature (2007) 7.12
Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature (2007) 7.04
Adding new chemistries to the genetic code. Annu Rev Biochem (2010) 6.32
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med (2007) 6.05
Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc Natl Acad Sci U S A (2002) 6.00
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A (2009) 5.86
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A (2002) 5.81
Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science (2010) 5.50
Lambda interferon inhibits hepatitis B and C virus replication. J Virol (2005) 5.47
Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A (2002) 5.28
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc Natl Acad Sci U S A (2008) 4.80
An expanded eukaryotic genetic code. Science (2003) 4.66
CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol (2003) 4.42
Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol (2006) 3.84
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci U S A (2005) 3.83
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc Natl Acad Sci U S A (2006) 3.83
Addition of a photocrosslinking amino acid to the genetic code of Escherichiacoli. Proc Natl Acad Sci U S A (2002) 3.77
Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature (2010) 3.71
Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol (2007) 3.57
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci U S A (2012) 3.50
Genetic incorporation of unnatural amino acids into proteins in mammalian cells. Nat Methods (2007) 3.45
Expanding the genetic code. Annu Rev Biophys Biomol Struct (2006) 3.36
Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility. Nat Chem Biol (2008) 3.23
A stem cell-based approach to cartilage repair. Science (2012) 3.22
An enhanced system for unnatural amino acid mutagenesis in E. coli. J Mol Biol (2009) 3.20
Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A (2004) 3.16
The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci U S A (2008) 3.13
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest (2010) 3.10
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science (2011) 3.07
Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics (2005) 2.99
Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol (2005) 2.94
The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci U S A (2009) 2.91
Addition of p-azido-L-phenylalanine to the genetic code of Escherichia coli. J Am Chem Soc (2002) 2.88
Addition of the keto functional group to the genetic code of Escherichia coli. Proc Natl Acad Sci U S A (2002) 2.84
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci U S A (2009) 2.80
Expanding the genetic code. Angew Chem Int Ed Engl (2004) 2.78
Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol (2006) 2.77
Genomically recoded organisms expand biological functions. Science (2013) 2.73
Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A (2002) 2.71
Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol (2006) 2.68
Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol (2006) 2.65
Self-renewal of embryonic stem cells by a small molecule. Proc Natl Acad Sci U S A (2006) 2.65
Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci U S A (2003) 2.64
An efficient rapid system for profiling the cellular activities of molecular libraries. Proc Natl Acad Sci U S A (2006) 2.51
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci U S A (2013) 2.49
Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A (2010) 2.46
Genome-scale functional profiling of the mammalian AP-1 signaling pathway. Proc Natl Acad Sci U S A (2003) 2.45
A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta. Proc Natl Acad Sci U S A (2008) 2.39
A chemical toolkit for proteins--an expanded genetic code. Nat Rev Mol Cell Biol (2006) 2.39
Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe (2009) 2.33
Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc Natl Acad Sci U S A (2007) 2.33
Recombinant expression of selectively sulfated proteins in Escherichia coli. Nat Biotechnol (2006) 2.31
Genome-wide functional analysis of human cell-cycle regulators. Proc Natl Acad Sci U S A (2006) 2.31
Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe (2012) 2.25
Efficient incorporation of unnatural amino acids into proteins in Escherichia coli. Nat Methods (2006) 2.24
Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med (2005) 2.19
Oxysterols direct immune cell migration via EBI2. Nature (2011) 2.19
Substrate recognition by the AAA+ chaperone ClpB. Nat Struct Mol Biol (2004) 2.19
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol (2005) 2.13
An expanded genetic code with a functional quadruplet codon. Proc Natl Acad Sci U S A (2004) 2.09
PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol (2007) 2.08
Synthetic small molecules that control stem cell fate. Proc Natl Acad Sci U S A (2003) 2.06
Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J Virol (2002) 2.05
A facile system for encoding unnatural amino acids in mammalian cells. Angew Chem Int Ed Engl (2009) 2.02
Control of protein phosphorylation with a genetically encoded photocaged amino acid. Nat Chem Biol (2007) 1.99
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids. Proc Natl Acad Sci U S A (2012) 1.99
Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci U S A (2004) 1.96
Identification of small molecule activators of cryptochrome. Science (2012) 1.95
A role for chemistry in stem cell biology. Nat Biotechnol (2004) 1.95
A genetically encoded fluorescent amino acid. J Am Chem Soc (2006) 1.93
The site-specific incorporation of p-iodo-L-phenylalanine into proteins for structure determination. Nat Biotechnol (2004) 1.93
Adding amino acids with novel reactivity to the genetic code of Saccharomyces cerevisiae. J Am Chem Soc (2003) 1.93
Replication of a hepatitis C virus replicon clone in mouse cells. Virol J (2006) 1.90
Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver. Hepatology (2014) 1.89
Exploring the limits of codon and anticodon size. Chem Biol (2002) 1.89
Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci U S A (2006) 1.88
Imaging nanometer domains of beta-adrenergic receptor complexes on the surface of cardiac myocytes. Nat Chem Biol (2005) 1.88
Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. Immunity (2005) 1.83
Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell (2008) 1.80
Deeply inverted electron-hole recombination in a luminescent antibody-stilbene complex. Science (2008) 1.79
A combinatorial scaffold approach toward kinase-directed heterocycle libraries. J Am Chem Soc (2002) 1.79
A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase. Proc Natl Acad Sci U S A (2006) 1.78
A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell (2009) 1.78
A general approach to site-specific antibody drug conjugates. Proc Natl Acad Sci U S A (2014) 1.77
Directed evolution of the site specificity of Cre recombinase. Proc Natl Acad Sci U S A (2002) 1.77
Profiling protein function with small molecule microarrays. Proc Natl Acad Sci U S A (2002) 1.77
Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A (2009) 1.76
An efficient system for the evolution of aminoacyl-tRNA synthetase specificity. Nat Biotechnol (2002) 1.73
Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity. Nat Cell Biol (2009) 1.73
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol (2006) 1.73
A genetically encoded metabolically stable analogue of phosphotyrosine in Escherichia coli. ACS Chem Biol (2007) 1.72
A genetically encoded infrared probe. J Am Chem Soc (2006) 1.71
The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol (2009) 1.71